Conference
124 RANDOMIZED PHASE II CLINICAL TRIAL OF INTRATUMORAL INJECTION OF JX-594, A TARGETED MULTI-MECHANISTIC ONCOLYTIC POXVIRUS, IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Authors
Heo J; Reid T; Lim HY; Ruo L; Kim CW; Bloomston M; Chung HC; Rhee BG; Patt R; Breitbach CJ
Volume
52
Publisher
Elsevier
Publication Date
January 1, 2010
DOI
10.1016/s0168-8278(10)60126-2
Conference proceedings
Journal of Hepatology
ISSN
0168-8278